| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/04/2011 | US20110189232 RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 |
| 08/04/2011 | US20110189231 Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines |
| 08/04/2011 | US20110189229 Vaccine against hpv |
| 08/04/2011 | US20110189228 Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof |
| 08/04/2011 | US20110189226 Immunization Compositions and Methods |
| 08/04/2011 | US20110189225 Attenuated bacteria useful in vaccines |
| 08/04/2011 | US20110189224 Pestivirus replicons providing an rna-based viral vector system |
| 08/04/2011 | US20110189223 Vaccine |
| 08/04/2011 | US20110189219 Sialic acid to support the immune system in the elderly |
| 08/04/2011 | US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine |
| 08/04/2011 | US20110189215 Vaccine Comprising Protein NMB0964 From Neisseria Meningitidis |
| 08/04/2011 | US20110189213 Mybl2 epitope peptides and vaccines containing the same |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189209 Fold-back diabody diphtheria toxin immunotoxin and methods of use |
| 08/04/2011 | US20110189208 Tb vaccine |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189201 Modulation of bone development |
| 08/04/2011 | US20110189200 Methods of treating autoimmune diseases with dll4 antagonists |
| 08/04/2011 | US20110189196 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |
| 08/04/2011 | US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189180 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 08/04/2011 | US20110189178 Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189150 Tangential flow filtration devices and methods for leukocyte enrichment |
| 08/04/2011 | US20110189141 Multiple target t cell receptor |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189129 Hepatitis c virus inhibitors |
| 08/04/2011 | US20110189123 Mammalian cx3c chemokine antibodies |
| 08/04/2011 | US20110189106 Intranasal compositions, dosage forms and methods of treatment |
| 08/04/2011 | US20110189083 Dock-and-Lock (DNL) Vaccines for Cancer Therapy |
| 08/04/2011 | CA2788224A1 Pyrazole compounds as crth2 antagonists |
| 08/04/2011 | CA2787615A1 Methods of treating diabetes with dll4 antagonists |
| 08/04/2011 | CA2787394A1 Methods of treating autoimmune diseases with dll4 antagonists |
| 08/04/2011 | CA2787321A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2787315A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2787070A1 Cd127 binding proteins |
| 08/04/2011 | CA2786994A1 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| 08/04/2011 | CA2786817A1 Extracellular ifi16 as therapeutic agents |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | CA2781314A1 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351840A1 Polypeptides involved in immune response |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351832A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 08/03/2011 | EP2351771A1 Immunosuppressive peptide |
| 08/03/2011 | EP2351769A2 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom |
| 08/03/2011 | EP2351767A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/03/2011 | EP2351764A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 08/03/2011 | EP2351757A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2351492A1 Nutritional composition with probiotics |
| 08/03/2011 | EP2350282A1 Increased expression of specific antigens |
| 08/03/2011 | EP2350280A1 Immunosuppression compound and treatment method |
| 08/03/2011 | EP2350132A2 A1 moiety of cholera toxin a subunit as an adjuvant for mucosal and systemic vaccines |
| 08/03/2011 | EP2350120A1 Multiligand constructs |
| 08/03/2011 | EP2350078A2 Compounds that expand hematopoietic stem cells |
| 08/03/2011 | EP2350004A1 Compounds for inflammation and immune-related uses |
| 08/03/2011 | EP2349311A1 Compositions and methods for treatment of radiation exposure |
| 08/03/2011 | EP2349294A1 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus |
| 08/03/2011 | EP2349291A2 Agonists of toll-like receptor 5 for the treatment of graft-versus-host disease |
| 08/03/2011 | EP2349277A2 Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (nr1f3) activity |
| 08/03/2011 | EP2348890A1 Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings |
| 08/03/2011 | EP2211892B1 Compositions comprising myelin basic protein peptides and medical uses thereof |
| 08/03/2011 | EP1833791B1 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | EP1317282B1 Vectors for molecule delivery to cd11b expressing cells |
| 08/03/2011 | EP1078092B1 Expression vectors for stimulating an immune response and methods of using the same |
| 08/03/2011 | CN1891687B Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 08/03/2011 | CN1890218B Tubulin inhibitors |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143949A 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102140104A 1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102139105A Immunotherapy method |
| 08/03/2011 | CN102139098A Lysozyme-rich novel biological synergist |
| 08/03/2011 | CN102139052A Disease-prevention and healthcare Chinese medicinal preparation for breeding pig |
| 08/03/2011 | CN102139015A Medicinal liquor capable of balancing yin and yang and improving immunity and preparation thereof |
| 08/03/2011 | CN102139013A Health care tonic wine for strengthening yang |
| 08/03/2011 | CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
| 08/03/2011 | CN102138981A Preparation method of plantago seed polysaccharide extractive and applications thereof |
| 08/03/2011 | CN102138965A Halenia elliptica D.Don extract and preparation method, pharmaceutical composition and application thereof |
| 08/03/2011 | CN102138947A Propolis Chinese medicinal composition |
| 08/03/2011 | CN102138945A Method of extracting active substances with high content of flavones from ginkgo leaves |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN102138914A Film-form preparation |
| 08/03/2011 | CN102138908A Thymopentin lyophilization powder injection for injection and preparation process thereof |
| 08/03/2011 | CN102138903A Everolimus solid oral medicinal composition |
| 08/03/2011 | CN101804174B Traditional Chinese medicine preparation for treating sicca syndrome |
| 08/03/2011 | CN101787000B M-stage kinesin inhibitor |
| 08/03/2011 | CN101716215B Quality detection method of traditional Chinese medicine of isatis root |
| 08/03/2011 | CN101628012B Medicine composition with function of regulating immunity and preparation method thereof |
| 08/03/2011 | CN101618019B Triamcinolone acetonide acetate particle, and preparation method and medicinal composition thereof |
| 08/03/2011 | CN101495632B Humanized anti-human osteopontin antibody |
| 08/03/2011 | CN101311190B Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof |
| 08/03/2011 | CN101244255B Thymus gland pentapeptide injection and uses thereof |
| 08/03/2011 | CN101184756B Isoflavonoid dimers |